直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Podcast

Life Sciences Podcast Series - Inherency and Obviousness

April 29, 2021

By Jill K. MacAlpine, Ph.D.; Alissa K. Lipton; Sara A. Leiman, Ph.D.; Oulu (Lulu) Wang, Ph.D.

The Life Sciences industry can be particularly challenging for companies to navigate, often requiring careful navigation through rigorous testing and regulatory compliance. The Life Sciences Podcasts Series looks at some of the hottest topics in the Life Sciences industry. In this podcast, Finnegan attorneys Jill MacAlpine, Alissa Lipton, Lulu Wang, and Sara Leiman discuss the doctrine of inherency and obviousness and identify notable, recent decisions in the life sciences industry.

Tags

Life Sciences Podcast Series , Obviousness (35 USC § 103), prior art

Downloadable Files

  • Life Sciences Podcast Series - Inherency and Obviousness

Related Practices

Global IP Enforcement, Litigation, and Trials

Related Industries

Life Sciences

Pharmaceutical

Related Offices

Boston, MA

Washington, DC

Related Professionals

Alissa K. Lipton
Partner
Washington, DC
+1 202 408 4293
Email
Sara A. Leiman, Ph.D.
Associate
Boston, MA
+1 617 646 1651
Email

Related Insights

Conference

Georgia Life Sciences Summit 2026

August 25-26, 2026

Sandy Springs

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

Conference

BIA Start-up Festival

May 21, 2026

London

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Conference

2026 Advanced Chemical & Biotech Patent Institute

May 11-12, 2026

San Francisco

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP